Physiological Basis
Following radical prostatectomy for prostate cancer, cavernosal nerve-sparing or non-nerve-sparing dissection disrupts the autonomic innervation of the corpus cavernosum to varying degrees. The cavernosal nerves — branches of the pelvic plexus running within the neurovascular bundles along the posterolateral surface of the prostate — are responsible for the parasympathetic nitric oxide release that initiates smooth muscle relaxation and erection. In the post-operative period, even after technically successful nerve-sparing surgery, cavernosal nerve function is transiently or permanently impaired by surgical trauma, traction injury, thermal spread, or neuropraxia. The consequence is a period of cavernosal hypoxia: in the absence of nocturnal or reflexogenic erections (which deliver oxygenated blood to the corpus cavernosum via cavernosal artery dilation), corporal smooth muscle cells exist in a relatively hypoxic microenvironment.
Sustained cavernosal hypoxia initiates a well-documented fibrotic cascade: smooth muscle cells undergo apoptosis and are progressively replaced by collagen-producing fibroblasts, resulting in corporal fibrosis — a permanent structural alteration of the corpus cavernosum that impairs its capacity for vascular engorgement and erection regardless of neural recovery. The extent of corporal fibrosis developing during the nerve recovery period is a major determinant of the ultimate erectile function outcome, independent of the degree of cavernosal nerve preservation achieved surgically. Penile rehabilitation is a structured intervention designed to interrupt this fibrotic process by delivering regular oxygenated blood flow to the corpora cavernosa during the recovery window — mechanically substituting for the absent physiological erection mechanism until spontaneous neural recovery occurs.
The same pathophysiological principle applies following penile prosthesis explantation (removal of an infected or malfunctioning implant), extensive Peyronie's disease grafting surgery involving significant corporotomy, or any procedure that substantially disrupts cavernosal tissue architecture or blood supply. In each case, the period immediately following surgery represents a critical window during which active rehabilitation can preserve the tissue substrate that future erectile function — spontaneous or device-assisted — requires.
The Treatment Protocol
A complete penile rehabilitation protocol integrates four complementary components, each targeting a distinct aspect of cavernosal tissue preservation. The vacuum erection device (VED) is the mechanical foundation of the protocol: a transparent acrylic cylinder placed over the penis connected to a vacuum pump that generates negative pressure, passively drawing blood into the cavernosal sinusoids and producing passive engorgement of the corpus cavernosum without dependence on cavernosal nerve function. Daily VED use for 10 to 15 minutes — typically once or twice daily — beginning as early as 4 to 6 weeks post-operatively (once wound healing is confirmed by the primary surgeon) delivers oxygenated blood to the cavernosal tissue on a schedule that partially compensates for absent physiological nocturnal erections. A constriction ring is not used during rehabilitation VED sessions, as the therapeutic goal is passive oxygenation rather than sustained erection for sexual activity.
Daily low-dose tadalafil (2.5–5 mg orally each morning) provides continuous background PDE5 inhibition throughout the rehabilitation period. Even in the early post-operative period when functional erections are absent, any residual cavernosal nerve activity — however minimal — can be amplified by PDE5 inhibition to produce partial engorgement during sleep, supplementing the VED-mediated oxygenation. Daily tadalafil also exerts direct anti-fibrotic effects on cavernosal smooth muscle cells, demonstrated in pre-clinical models to include upregulation of smooth muscle differentiation markers and suppression of pro-fibrotic TGF-β1 signalling. Low-intensity shockwave therapy (Li-ESWT), initiated at 3 to 6 months post-operatively once wound healing is complete, augments the rehabilitation protocol by stimulating neovascularisation within the recovering cavernosal tissue — restoring microvasculature density depleted by post-surgical hypoxia and supporting the metabolic environment required for nerve regeneration. Platelet-rich plasma or PRF injections represent an optional fourth component for practices offering growth factor augmentation as part of the rehabilitation protocol.
Who is a Candidate
Penile rehabilitation is indicated for all men undergoing radical prostatectomy — both nerve-sparing and non-nerve-sparing — as the cavernosal hypoxia and potential for corporal fibrosis affects both groups during the recovery period, with only the degree of eventual neural recovery differing between them. Men recovering from penile prosthesis explantation face a specific form of post-surgical corporal change — fibrosis and scarring around the former implant — that active rehabilitation may partially mitigate before planned reimplantation. Men who have undergone extensive Peyronie's disease surgical correction involving corporotomy and grafting face analogous healing-phase tissue vulnerability. Any man who remains more than 12 to 18 months from radical prostatectomy without having received structured rehabilitation represents a missed opportunity window, though late initiation of Li-ESWT and daily tadalafil may still provide marginal benefit even outside the primary rehabilitation period.
The rehabilitation protocol must be individualised to the specific surgical history, wound healing status, and comorbidity profile of each patient. The primary surgeon's clearance for VED use and the specific protocol start dates for each component are essential — premature VED use before wound healing is contraindicated and potentially harmful.
Expected Outcomes and Timeline
Penile rehabilitation does not guarantee return of spontaneous erectile function — this depends primarily on the degree of cavernosal nerve injury sustained during surgery and the patient's pre-operative vascular and neurological baseline. What structured rehabilitation consistently achieves is maximisation of the tissue preservation environment: men who complete a structured rehabilitation programme demonstrate better cavernosal smooth muscle preservation on biopsy, higher rates of functional erectile recovery at 12 and 24 months, and shorter time-to-first-erection compared to those who take a passive "wait and see" approach in published comparative series. The rehabilitation outcome should be framed not as a guarantee of spontaneous erection recovery but as the optimisation of the probability and quality of recovery — and as the preservation of the tissue architecture required for penile prosthesis function if surgical implantation is ultimately elected.
The 18 to 24 months following nerve-sparing radical prostatectomy represents the primary nerve recovery window during which spontaneous erectile function can return. Recovery occurring beyond this window is uncommon. Structured rehabilitation aims to keep the cavernosal tissue viable and responsive throughout this window, maximising the benefit realised from whatever degree of neural recovery the surgery allows. Regular follow-up assessments at 3, 6, 12, and 18 months allow the treating urologist to adjust protocol intensity and, at the appropriate decision point, counsel the patient regarding the likely trajectory and the role of PDE5 inhibitor therapy, on-demand vacuum assistance, or prosthetic surgery in their long-term management.
Safety Profile and Risks
The vacuum erection device is non-invasive and has an excellent safety profile. Petechiae — small pinpoint subdermal haemorrhages on the penile skin from vacuum-induced negative pressure — are common, cosmetically minor, and resolve spontaneously within days. Ecchymosis (bruising) from excessive vacuum pressure or prolonged session duration is uncommon with adherence to the recommended 10 to 15 minute session duration. VED devices must not be used with a constriction ring during the post-operative rehabilitation period when wound healing is ongoing, as constriction rings impair venous outflow and can compromise healing tissue. Daily low-dose tadalafil carries the same adverse effect profile as described in the PDE5 inhibitor optimisation section — headache, flushing, and myalgia are the most commonly reported effects, generally mild and diminishing with continued use. Li-ESWT adverse effects are minimal as described in the Li-ESWT section.
Cost and Accessibility
The VED is a one-time device purchase ($150 to $400 for a medical-grade prescription vacuum erection device; some insurance plans cover this under durable medical equipment benefits when prescribed for post-prostatectomy rehabilitation). Daily generic tadalafil is inexpensive — $30 to $100 per month through pharmacy discount programmes. Li-ESWT and PRP/PRF components add $3,000 to $6,000 and $2,000 to $5,000 respectively when incorporated. The overall programme cost is modest relative to the potential benefit of preserving native erectile tissue, particularly when compared to the cost of penile prosthesis surgery (typically $20,000 to $30,000 including facility fees) that structured rehabilitation may defer or render unnecessary.
Selecting a Qualified Provider
Penile rehabilitation following radical prostatectomy is best managed by an ABU board-certified urologist with dedicated sexual medicine or andrological subspecialty training — ideally the primary surgeon, or a sexual medicine specialist with direct communication with the operative team. SMSNA membership reflects engagement with the evolving evidence standards and published rehabilitation protocols in this subspecialty. Providers should be able to articulate a specific, evidence-based rehabilitation protocol — not merely offer a general recommendation to "use a VED and take a pill" — including specific device recommendations, dosing instructions, start dates, and a structured follow-up schedule. Centres that integrate Li-ESWT and regenerative injection into their rehabilitation protocols for appropriate candidates represent the current leading edge of evidence-based post-prostatectomy sexual medicine care.